Skip to content

Clinical trials

Withdrawn Immunoblastic Lymphadenopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Withdrawn Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20141
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center1
Northwestern University1
University of Medicine and Dentistry of New Jersey1
University of Miami1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy5
Lymphoma, Extranodal NK-T-Cell4
Lymphoma, Large-Cell, Anaplastic4
Lymphoma, T-Cell, Cutaneous4
Mycosis Fungoides4
Sezary Syndrome4
Burkitt Lymphoma3
Hodgkin Disease3
Intraocular Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.